Moreover, accumulating evidence has demonstrated that FOXD1 is implicated in the carcinogenesis, including lung cancer [7], colorectal cancer [8], ovarian cancer [9], breast cancer [10], nasopharyngeal carcinoma [11], gastric cancer [12], and prostate cancer [13]. This evidence concerns the gene FOXD1 and ovarian carcinoma.